Nina Garlo examines the effectiveness of antibacterial treatment for periodontitis.

A groundbreaking study in Lithuania, LumoKaunas2023, has been launched to examine the effectiveness of antibacterial, light-activated therapy in treating severe periodontitis. Established in August 2023 in Kaunas, the study is investigating the regular use of the Lumoral device as an adjunct therapy for managing chronic stage III to IV periodontitis.

The study, led by Ingrida Pacauskiené, aims to recruit 60 participants, with 38 already enrolled.

The Lumoral device, developed by Finnish scientists, combines a specialised mouthwash with antibacterial dual-light therapy. Building on findings from the earlier HOPE-CP study, which demonstrated its efficacy in managing early-stage periodontitis, LumoKaunas2023 focuses on more advanced cases requiring intensive treatment.

The role of antibacterial therapy

The HOPE-CP study revealed significant benefits of the Lumoral device in managing gum disease. Among participants using Lumoral, 54 per cent showed healing of gum inflammation, compared to 22 per cent in the control group. The device also reduced plaque buildup and halved deep gum pockets in 67 per cent of users, significantly better results than in the control group. These findings underscore the importance of addressing dental plaque bacteria, the primary cause of gum disease, with antibacterial oral hygiene-enhancing methods as part of traditional oral hygiene practices.

Periodontitis, a serious condition causing gum inflammation and tissue damage, often progresses silently until severe symptoms like pain or tooth loss emerge. The antibacterial effects of the device provide an innovative treatment option. Tommi Pätilä, Lumoral co-developer, said, "Regular elimination of dental plaque significantly improves oral hygiene and supports both prevention and treatment of gum disease."

Implications for the dental team

Dental nurses and hygienists are pivotal in promoting effective at-home care. The Lumoral device complements professional treatments by enabling patients to maintain high oral hygiene standards between visits.

Tommi said, “Antibacterial treatment combined with professional care reduces oral infections.” By recommending tools like Lumoral, dental nurses empower patients to take control of their oral health, reducing dependency on antibiotics and enhancing treatment outcomes.

Dental nurses are also key educators, ensuring proper usage of at-home antibacterial therapies, which minimise bacterial loads and lower infection risks. This collaboration between home care and clinical interventions aligns with global efforts to combat antibiotic resistance, highlighting the essential role of dental professionals in modern periodontal care.

Future Perspectives

The LumoKaunas2023 study highlights international collaboration in advancing periodontal treatment. With recruitment progressing, the study is set to conclude in autumn 2025, providing critical insights into managing severe gum disease.

Mikko Kylmänen, clinical research manager for Koite Health, said, “We’re excited to gather more evidence on how Lumoral enhances treatment outcomes, especially for severe cases.”

As periodontal treatment evolves, the Lumoral device offers an exciting adjunct to traditional methods, potentially revolutionising care for patients with advanced gum disease.

References available on request.

Author: